Michael Schreck - 14 Feb 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael Schreck
Issuer symbol
IDXX
Transactions as of
14 Feb 2024
Net transactions value
-$65,586
Form type
4
Filing time
16 Feb 2024, 17:58:00 UTC
Previous filing
05 Jan 2024
Next filing
04 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +80 +15% $0.000000 615 14 Feb 2024 Direct
transaction IDXX Common Stock Options Exercise $0 +118 +19% $0.000000 733 14 Feb 2024 Direct
transaction IDXX Common Stock Options Exercise $0 +170 +23% $0.000000 903 14 Feb 2024 Direct
transaction IDXX Common Stock Tax liability $65,586 -117 -13% $560.56 786 14 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +5,407 $0.000000 5,407 14 Feb 2024 Common Stock 5,407 $560.56 Direct F1
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +178 $0.000000 178 14 Feb 2024 Common Stock 178 $560.56 Direct F2
transaction IDXX Restricted Stock Unit Award $0 +1,204 $0.000000 1,204 14 Feb 2024 Common Stock 1,204 Direct F3
transaction IDXX Restricted Stock Unit Options Exercise $0 -80 -50% $0.000000 80 14 Feb 2024 Common Stock 80 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -118 -34% $0.000000 234 14 Feb 2024 Common Stock 118 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -170 -25% $0.000000 508 14 Feb 2024 Common Stock 170 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
F2 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
F3 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
F4 Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on February 14, 2022.
F5 Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four equal annual installments beginning on February 14, 2023.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four equal annual installments beginning on February 14, 2024.